Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
67%(4 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
2
25%
Ph phase_3
3
38%
Ph phase_4
3
38%

Phase Distribution

0

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(2)

Detailed Status

Completed6
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 33 (37.5%)
Phase 43 (37.5%)

Trials by Status

withdrawn113%
completed675%
terminated113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_3

IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)

NCT00202878
withdrawnphase_4

A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)

NCT01587235
completedphase_2

Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes

NCT00477204
completedphase_4

Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment

NCT00819403
completedphase_2

Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy

NCT02129231
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00202878Phase 3

IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)

Completed
NCT01587235Phase 4

A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)

Withdrawn
NCT00477204Phase 2

Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes

Completed
NCT00819403Phase 4

Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment

Completed
NCT02129231Phase 2

Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy

Completed
NCT00461630Phase 3

Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE

Completed
NCT00905905Phase 4

Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction

Completed
NCT00267267Phase 3

A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

Terminated

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8